Chatbot ‘Gene to help with hereditary cancer

Chatbot ‘Gene' to help with hereditary cancer

Myriad Genetics, Inc. announced a new collaboration with OptraHEALTH to implement a cognitive chatbot named Gene to provide genetic and financial assistance information to prospective patients.

Gene is an AI-powered, HIPAA-compliant knowledge platform for genetic health with bot interfaces and that will be able to answer more than 500,000 patient-level questions involving health, genetics and healthcare-related finances. Gene will also interface with Myriad’s market leading online hereditary cancer quiz that engages around one million people per year. “We are excited to offer this innovative new tool for physicians and patients to provide best-in-class pre-test education solutions that we can supplement with live sessions when necessary,” said Nicole Lambert, president of Myriad International, Oncology and Women’s Health.

“Myriad is highly focused on making the screening and testing process as streamlined as possible for healthcare providers and the implementation of this new technology will give their patients access to unparalleled online genetic education and support tools. This is especially important in the current environment with COVID-19 where patients may not be returning to the clinic setting and pre-test education can be particularly helpful as they work remotely with the healthcare provider to determine if testing is right for them.”

Gene will interactively engage individuals online, providing them with education about hereditary cancer prior to taking an online assessment to determine if they may be a candidate for genetic testing. For those who complete the preliminary assessment and meet criteria for further evaluation, Gene will automate a pre-test process that sends an educational link that displays interactive multimedia content and gives the option to start a live conversation with a patient educator, who is a certified genetic counselor. Gene can also assist in finding a healthcare provider who can help a patient make an informed, definitive decision whether testing is appropriate and then order testing if so. 

Myriad plans on launching the Gene chatbot for its Foresight and Prequel prenatal tests and for companion diagnostic testing in oncology later this calendar year.

Subscribe to our newsletter

Related articles

Lung cancer: AI could predict risk of recurrence

Lung cancer: AI could predict risk of recurrence

Computer scientists working with pathologists have trained an AI tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.

AI model accurately classifies colorectal polyps

AI model accurately classifies colorectal polyps

An AI model for automated classification of colorectal polyps could benefit cancer screening programs by improving efficiency, reproducibility, and accuracy.

AI tracks down acute myeloid leukemia

AI tracks down acute myeloid leukemia

Artificial intelligence can detect one of the most common forms of blood cancer—acute myeloid leukemia (AML)—with high reliability.

AI detects even the smallest metastases

AI detects even the smallest metastases

Researchers have developed a new algorithm that enables automated detection of metastases at the level of single disseminated cancer cells in whole mice.

ConvPath software uses AI to identify cancer cells

ConvPath software uses AI to identify cancer cells

A software tool uses artificial intelligence to recognize cancer cells from digital pathology images — giving clinicians a powerful way of predicting patient outcomes.

Deep learning identifies molecular patterns of cancer

Deep learning identifies molecular patterns of cancer

An AI platform can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process.

Deep learning assists in detecting malignant lung cancers

Deep learning assists in detecting malignant lung cancers

Radiologists assisted by deep learning based software were better able to detect malignant lung cancers on chest X-rays.

AI system predicts which cancer patients benefit from immunotherapy

AI system predicts which cancer patients benefit from immunotherapy

Using machine learning, researchers have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are likely to benefit from immunotherapy.

Using AI to predict risk of thyroid cancer on ultrasound

Using AI to predict risk of thyroid cancer on ultrasound

Researchers from Thomas Jefferson University use machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.

Popular articles